Besiktas, Turkey

Busecan Aksoydan

This inventor holds 1 USPTO granted patent. Top assignees: Agri Ibrahim Cecen Universitesi Strateji Daire Bask., Bahçesehir Üniversitesi, Istanbul Gedik Universitesi. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Busecan Aksoydan. Retrieved from https://idiyas.com/inventor/busecan-aksoydan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Busecan Aksoydan: Innovator in Neurodegenerative Disease Treatment

Introduction

Busecan Aksoydan is a notable inventor based in Besiktas, Istanbul, Turkey. He has made significant contributions to the field of neurodegenerative diseases through his innovative research and development.

Latest Patents

Busecan Aksoydan holds 1 patent for his invention titled "Selective MAO-B inhibitor DRG-MAOB-2 for use in treatment of neurodegenerative diseases." This invention relates to a compound represented by formula (I) or a pharmaceutically acceptable derivative thereof, which serves as a novel inhibitor of MAO-B.

Career Highlights

Throughout his career, Busecan has worked with esteemed institutions such as Bahçeşehir University and Ağrı İbrahim Çeçen University, where he has contributed to various research initiatives and academic programs.

Collaborations

Busecan has collaborated with notable colleagues, including Serdar Durdagi and Mine Yurtsever, enhancing the impact of his work in the scientific community.

Conclusion

Busecan Aksoydan's innovative approach to treating neurodegenerative diseases through his patented invention highlights his commitment to advancing medical science. His contributions are paving the way for future developments in this critical area of healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…